uz
Feedback
pharmacy all semester notes and study material previous year qus

pharmacy all semester notes and study material previous year qus

Kanalga Telegram’da oā€˜tish

B PHARMACY previous year qus paper NOTES , BooKs ( B/D PHARMACY) 🟢 Search the name of file and you got it in channel #pharmacynotes #PharmaD #medical #Pharmacist #Dpharmacy šŸ™ JOIN US AND SUPPORT

Ko'proq ko'rsatish
5 827
Obunachilar
-324 soatlar
-67 kunlar
-1730 kunlar
Obunachilarni jalb qilish
Avgust '26
Avgust '26
+58
0 kanalda
Iyul '26
+78
0 kanalda
Get PRO
Iyun '26
+88
0 kanalda
Get PRO
May '26
+88
0 kanalda
Get PRO
Aprel '26
+77
0 kanalda
Get PRO
Mart '26
+39
0 kanalda
Get PRO
Fevral '26
+40
0 kanalda
Get PRO
Yanvar '26
+69
0 kanalda
Get PRO
Dekabr '25
+69
0 kanalda
Get PRO
Noyabr '25
+65
0 kanalda
Get PRO
Oktabr '25
+65
0 kanalda
Get PRO
Sentabr '25
+119
0 kanalda
Get PRO
Avgust '25
+96
0 kanalda
Get PRO
Iyul '25
+117
0 kanalda
Get PRO
Iyun '25
+111
0 kanalda
Get PRO
May '25
+65
0 kanalda
Get PRO
Aprel '25
+60
0 kanalda
Get PRO
Mart '25
+65
0 kanalda
Get PRO
Fevral '25
+49
0 kanalda
Get PRO
Yanvar '25
+100
0 kanalda
Get PRO
Dekabr '24
+164
0 kanalda
Get PRO
Noyabr '24
+192
0 kanalda
Get PRO
Oktabr '24
+245
0 kanalda
Get PRO
Sentabr '24
+241
1 kanalda
Get PRO
Avgust '24
+287
1 kanalda
Get PRO
Iyul '24
+663
0 kanalda
Get PRO
Iyun '24
+797
0 kanalda
Get PRO
May '24
+923
0 kanalda
Get PRO
Aprel '24
+816
0 kanalda
Get PRO
Mart '24
+855
0 kanalda
Get PRO
Fevral '24
+735
0 kanalda
Get PRO
Yanvar '240
0 kanalda
Get PRO
Dekabr '23
+59
0 kanalda
Get PRO
Noyabr '23
+746
0 kanalda
Sana
Obunachilarni jalb qilish
Esdaliklar
Kanallar
26 Avgust+4
25 Avgust+1
24 Avgust+2
23 Avgust+1
22 Avgust+1
21 Avgust0
20 Avgust+6
19 Avgust+3
18 Avgust+7
17 Avgust+3
16 Avgust0
15 Avgust+1
14 Avgust+2
13 Avgust+2
12 Avgust+3
11 Avgust+2
10 Avgust+5
09 Avgust+1
08 Avgust+2
07 Avgust0
06 Avgust+4
05 Avgust+1
04 Avgust+3
03 Avgust0
02 Avgust0
01 Avgust+4
Kanal postlari
2
Anyone from lonavala?? DM ME
886
3
🧠 Clinical Overview of Selected Psychoactive Substances 1. Heroin (Diacetylmorphine) Class: Semi-synthetic opioid, rapidly metabolized to morphine. ā­•ļøMechanism: μ-opioid receptor agonist → strong analgesia, euphoria, respiratory depression. Clinical Concerns: Rapid CNS penetration → intense addiction potential. Overdose: respiratory depression, pinpoint pupils, coma (ā€œopioid triadā€). Withdrawal: agitation, mydriasis, rhinorrhea, diarrhea, muscle cramps. šŸ’ŠAntidote: Naloxone (IV/IM/IN) for acute overdose. Long-term Risks: HIV, HCV (injection use), collapsed veins, endocarditis. 2. Mephedrone (4-methylmethcathinone, "Meow Meow") Class: Synthetic cathinone, stimulant (ā€œbath saltsā€). ā­•ļøMechanism: Increases synaptic dopamine, norepinephrine, serotonin (reuptake inhibition + release). Clinical Concerns: Acute: euphoria, hyperstimulation, increased sociability. Toxicity: tachycardia, hypertension, agitation, paranoia, seizures, hyperthermia. Chronic: neurotoxicity, dependence, psychiatric disorders. šŸ’ŠNo specific antidote → manage supportively (benzodiazepines for agitation/seizures, cooling for hyperthermia). 3. Cocaine Class: Stimulant, local anesthetic. ā­•ļøMechanism: Blocks reuptake of dopamine, norepinephrine, serotonin. Clinical Concerns: Acute: intense euphoria, tachycardia, hypertension, mydriasis. Complications: myocardial infarction (coronary vasospasm), stroke, seizures, sudden death. Chronic: septal perforation (snorting), psychiatric effects, strong addiction potential. šŸ’ŠTreatment of Toxicity: Benzodiazepines (for agitation, hypertension), avoid β-blockers (unopposed α-effect). 4. Caffeine Class: Methylxanthine stimulant. ā­•ļøMechanism: Adenosine receptor antagonist → ↑ CNS stimulation, ↑ catecholamines. Clinical Concerns: Moderate dose: alertness, reduced fatigue. High dose: anxiety, tachycardia, insomnia, GI upset. Toxic dose (>1 g): arrhythmias, seizures. Withdrawal: Headache, irritability, fatigue. 5. Dopamine (DA) Class: Endogenous catecholamine. ā­•ļøMechanism (dose-dependent): Low dose: D1 receptor → renal vasodilation. Moderate dose: β1 receptor → ↑ cardiac contractility. High dose: α1 receptor → vasoconstriction. šŸ’ŠClinical Use: Cardiogenic/septic shock (IV infusion). Adverse Effects: Tachyarrhythmias, extravasation necrosis (treat with phentolamine). 6. Opioids (general, incl. Morphine, Codeine, Fentanyl) Class: μ-opioid receptor agonists. Effects: Analgesia, sedation, respiratory depression, constipation, euphoria. Clinical Concerns: Overdose → respiratory arrest. Dependence & tolerance common. šŸ’ŠAntidote: Naloxone (short-acting), Naltrexone (maintenance). Clinical Uses: Pain, anesthesia, palliative care, cough, diarrhea. 7. Adrenaline (Epinephrine) Class: Endogenous catecholamine, adrenergic agonist. ā­•ļøMechanism: α1 → vasoconstriction, ↑ BP. β1 → ↑ HR, ↑ contractility. β2 → bronchodilation. āœ…ļøClinical Uses: Anaphylaxis (IM first-line). Cardiac arrest (IV/IO). Added to local anesthetics (vasoconstriction). Adverse Effects: Tachyarrhythmias, hypertension, anxiety, tremor. šŸ”‘ Key Clinical Pearls Heroin & opioids: respiratory depression is the killer → always think naloxone. Mephedrone & cocaine: sympathetic storm → benzodiazepines are first-line. Caffeine: mild compared to others, but toxicity at high doses. Dopamine & adrenaline: dose-dependent receptor activity → lifesaving in shock/anaphylaxis. šŸ“š References Pharmacotherapy Principles and Practice, 6th Edition American College of Clinical Pharmacy (ACCP) – Toxicology & Critical Care UpToDate (Opioid toxicity, Cocaine, Synthetic cathinones, Caffeine, Dopamine in shock, Epinephrine) Lexicomp (Lexi-Drugs Online) Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 13th Edition
1 207
4
Matn yo'q...
900
5
+1
Matn yo'q...
861
6
Matn yo'q...
788
7
Matn yo'q...
591
8
Matn yo'q...
633
9
Matn yo'q...
575
10
Matn yo'q...
497
11
Matn yo'q...
551
12
Matn yo'q...
598
13
https://youtu.be/namhmWyy0IE
143
14
https://youtu.be/aYUg06rA5-U
305
15
https://t.me/KnowldgeHubCtet Join our new teligram channel
869
16
https://youtube.com/shorts/cFhfGKdIyWg?si=pxIbLt9cbUlOCv5_
355
17
Like subscribe and share
812
18
https://youtu.be/hZGb_3sal-Q?si=C2ljwMQJePgHI34z
376
19
https://a.co/d/0hvaXjzj
1 076
20
Buy this product from Amazon.com
1 120